IP Verse

S1P Receptor Modulators For Treating Multiple Sclerosis

Patent No. EP2959894 (titled "S1P Receptor Modulators For Treating Multiple Sclerosis") was filed by Novartis on Jun 25, 2007. The application was issued on Oct 12, 2022.

Patent Summary

Anti-angiogenic drug to prevent or treating neo-angiogenesis associated with a demyelinating disease. The drug reduces the risk of demyelinating disease, including reduction of, alleviation of, stabilization of or relief from the symptoms which affect the organism.

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (24)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTELJul 12, 2023MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
GENERIS FARMACEUTICAJul 12, 2023-
ADAMED PHARMAJul 11, 2023VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
EGISJul 11, 2023STOLMAR & PARTNER
SYNTHONMay 22, 2023HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBBMay 10, 2023SONNENHAUSER
NEURAXPHARM ARZNEIMITTELMar 22, 2023ZBM PATENTS ZEA
SCJan 23, 2023DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBBJan 23, 2023DR. SCHÖN, NEYMEYR & PARTNER PATENTANWÄLTE MBB
BIOGARANJan 13, 2023CASALONGA
STADA ARZNEIMITTELJan 9, 2023HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
BAUSCH HEALTH IRELANDJan 2, 2023MAIWALD PATENT- UND RECHTSANWALTSGESELLSCHAFT MBH
VIVANTA GENERICS SRO MSN LABRATORIES PRIVATEDec 6, 2022HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
HEUMANN PHARMADec 5, 2022HAMM&WITTKOPP PATENTANWÄLTE PARTMBB
ACCORD HEALTHCAREDec 1, 2022HOFFMANN EITLE
A MEDNov 21, 2022GREINER
RAFARMNov 9, 2022BECKER KURIG & PARTNER PATENTANWALTE MBB
GENEPHARMNov 4, 2022ROUKOUNAS
ELPEN PHARMACEUTICALOct 20, 2022ROUKOUNAS
GENERICS UKOct 12, 2022GILL JENNINGS & EVERY
GLENMARK PHARMACEUTICALS EUROPEOct 12, 2022JOHNSON
PHARMATHENOct 12, 2022LAU
TEVA PHARMACEUTICAL INDUSTRIES LTDOct 12, 2022D YOUNG
ZENTIVA KSOct 12, 2022GREINER

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

EP2959894

NOVARTIS
Application Number
EP15177166A
Filing Date
Jun 25, 2007
Status
Granted And Under Opposition
Sep 9, 2022
Publication Date
Oct 12, 2022
External Links
Slate, Register , Google Patents